1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0513
    Methylthiouracil

    甲硫氧嘧啶

    Inhibitor ≥98.0%
    Methylthiouracil 是一种抗甲状腺剂。Methylthiouracil 抑制 TNF-αIL-6 的产生以及 NF-κBERK1/2 的活化。
    Methylthiouracil
  • HY-N7981
    Pratensein Inhibitor 99.92%
    Pratensein 是一种黄酮类化合物,通过减少氧化损伤和恢复突触和 BDNF 水平来改善 β-淀粉样蛋白诱导的大鼠认知障碍。
    Pratensein
  • HY-N6857
    Armepavine

    亚美罂粟碱; 杏黄罂粟碱; 亚美尼亚罂粟碱; 亚美异粟碱

    Inhibitor 99.53%
    Armepavine 是一种来自 Nelumbo nucifera 的活性化合物,不仅对人外周血单核细胞具有抗炎作用,且对 T 淋巴细胞和狼疮肾炎小鼠也具有免疫抑制作用。Armepavine 抑制 TNF-α 诱导的 MAPKNF-κB 信号级联反应。
    Armepavine
  • HY-N6636
    Valencene Inhibitor
    Valencene 是一种从 Cyperus rotundus 中分离出来的倍半萜类化合物,具有抗过敏、抗黑色素生成、抗炎和抗氧化活性。通过阻断NF-κB 通路,Valencene 抑制 Th2 趋化因子和促炎性趋化因子的过度表达。Valencene 用于食物和饮料调味。
    Valencene
  • HY-N3807
    Enniatin B1

    恩镰孢菌素 B1

    Inhibitor 99.34%
    Enniatin B1 是一种镰刀菌毒素。在大鼠肝微粒体酶实验中,Enniatin B1 抑制酰基辅酶 A:胆固醇酰基转移酶 (ACAT) 活性,IC50 为 73 μM。Enniatin B1 能透过血脑屏障。Enniatin B1 降低 ERK (p44/p42) 活化。Enniatin B1 抑制 TNF-α 诱导的 NF-κB激活。
    Enniatin B1
  • HY-76006
    3-Hydroxybenzaldehyde

    间羟基苯甲醛

    Inhibitor 99.85%
    3-Hydroxybenzaldehyde 是 Protocatechuic aldehyde (PCA) (HY-N0295) 等酚类化合物的前体化合物。3-Hydroxybenzaldehyde,由 3-hydroxybenzyl-alcohol 脱氢酶产生,是大鼠和人醛脱氢酶 (ALDH) 的底物 (substrate)。3-Hydroxybenzaldehyde 具有体内外血管保护作用。3-Hydroxybenzaldehyde 有望于动脉粥样硬化的研究 。
    3-Hydroxybenzaldehyde
  • HY-144765
    NF-κB-IN-4 Inhibitor 99.66%
    NF-κB-IN-4 (化合物 17) 是一种有效的可透过血脑屏障的 NF-κB 通路抑制剂。NF-κB-IN-4 表现出潜在的低毒性抗神经炎症活性。NF-κB-IN-4 可阻断 IκBα 的激活和磷酸化,降低 NLRP3 的表达,从而抑制 NF-κB 的激活。NF-κB-IN-4 可用于神经炎症相关疾病的研究。
    NF-κB-IN-4
  • HY-N7931
    Regaloside A

    王百合苷A

    Inhibitor 99.76%
    Regaloside A 是一种苯丙烷,在 160 ppm 时显示出 58.0% 的显着 DPPH 自由基清除活性。Regaloside A 具有抗炎活性。
    Regaloside A
  • HY-N0608
    Myrislignan Inhibitor 99.46%
    Myrislignan 是从Myristica fragrans Houtt 分离得到的一种木酚素,具有抗炎活性。Myrislignan 通过抑制NF-kB信号通路的激活,减轻LPS诱导的小鼠巨噬细胞炎症反应。
    Myrislignan
  • HY-15530
    CID-2858522 Inhibitor 99.78%
    CID-2858522 是一种高效的选择性抗原受体介导的 NF-κB 抑制剂,IC50 为 70 nM。
    CID-2858522
  • HY-157331
    DCZ5418 Inhibitor 99.02%
    DCZ5418 是 TRIP13 的抑制剂。DCZ5418 在体外和体内均具有抗多发性骨髓瘤活性。
    DCZ5418
  • HY-B1026
    Adelmidrol

    阿地米屈

    Inhibitor ≥98.0%
    Adelmidrol 发挥重要的抗炎作用,部分依赖于 PPARγ。Adelmidrol 降低 NF-κB 易位,和 COX-2 表达。
    Adelmidrol
  • HY-137941
    Roxatidine Inhibitor 98.25%
    Roxatidine 是 Roxatidine acetate 的活性代谢产物,是具有口服活性的组胺 H2 受体拮抗剂。Roxatidine 是抗溃疡剂,抑制组胺释放(从而抑制质子分泌)并抑制炎症和血管生成的重要标志物 VEGF-1 的产生。具有抗过敏性炎症作用。Roxatidine 有望用于胃和十二指肠溃疡的研究。
    Roxatidine
  • HY-14655S
    Sulfasalazine-d4

    柳氮磺吡啶 d4

    Inhibitor 99.28%
    Sulfasalazine-d4 是 Sulfasalazine 的氘代物。Sulfasalazine (NSC 667219) 常用于类风湿关节炎和溃疡性结肠炎的相关研究。Sulfasalazine 可抑制 NF-κB 的活性。Sulfasalazine 是 type 1 的铁死亡 (ferroptosis) 诱导剂。
    Sulfasalazine-d<sub>4</sub>
  • HY-N9396
    Nasunin Inhibitor 99.30%
    Nasunin 是一种抗氧化花青素、具有抗血管生成活性。
    Nasunin
  • HY-W089835
    Sodium taurodeoxycholate hydrate

    牛磺脱氧胆酸钠水合物

    Inhibitor
    Sodium taurodeoxycholate hydrate 是一种胆盐相关的阴离子洗涤剂。Sodium taurodeoxycholate hydrate 是在肝脏中将脱氧胆酸与 Taurine (HY-B0351) 偶联形成的。Sodium taurodeoxycholate hydrate 可用于分离膜蛋白,包括线粒体内膜蛋白。Taurodeoxycholate-d6 (TDCA) 具有抗炎和神经保护作用。。
    Sodium taurodeoxycholate hydrate
  • HY-N0276
    Flaconitine

    乙酰乌头碱

    Inhibitor 99.77%
    Flaconitine 是一种生物碱。Flaconitine 是一种 NF-κB 抑制剂。
    Flaconitine
  • HY-N0907
    Ginsenoside Rg6

    人参皂苷 Rg6

    Inhibitor 99.13%
    Ginsenoside Rg6 在 HepG2 细胞中抑制 TNF-α 诱导的 NF-κB 转录活性, IC50 为 29.34 μM。Ginsenoside Rg6 还具有细胞凋亡诱导作用。
    Ginsenoside Rg6
  • HY-N2855
    Alphitolic acid Inhibitor
    Alphitolic acid (Aophitolic acid) 是一种可以在槲栎植物中提取的抗炎三萜。Alphitolic acid 阻断 Akt-NF-κB 信号传导诱导细胞凋亡(apoptosis)。Alphitolic acid 可以诱导自噬 (autophagy)。Alphitolic acid 具有抗炎活性并下调 NO 和 TNF-α 的产生。Alphitolic acid 可以用作肿瘤和炎症的研究。
    Alphitolic acid
  • HY-152177
    JS6 Inhibitor 99.67%
    JS6 是 Bcl3 抑制剂,可抑制 Bcl3-NF-kB1 的结合。JS6 在体内外均抑制肿瘤细胞生长。
    JS6
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.